Davis J. E.'s Form 4 filing
Quest Diagnostics Inc (DGX) · filed Nov 28, 2025
- Accession no.
- 0001022079-25-000233
- Filed
- Nov 28, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $10.6M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis J. E.CIK 0001599837 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | MOption exerciseAcquired | +55,093 | $95.80 | +$5,277,909.4 | 175,573 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −9,342 | $191.59 | −$1,789,833.78 | 166,231 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −41,004 | $192.27 | −$7,883,839.08 | 125,227 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −4,747 | $192.97 | −$916,028.59 | 120,480 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | MOption exerciseDisposed | −55,093 | $95.80 | −$5,277,909.4 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.